>>> I WAS SHOCKED TO HEAR, THREE, FOUR WEEKS AGO, SAID HOW

THREE, FOUR WEEKS AGO, SAID HOW MANY PEOPLE A YEAR DIE FROM THE

MANY PEOPLE A YEAR DIE FROM THE FLU, IN THIS COUNTRY I THINK 36

FLU, IN THIS COUNTRY I THINK 36 OR 37,000 PEOPLE.

OR 37,000 PEOPLE. I’M SAYING WOW.

I’M SAYING WOW. NOBODY KNEW THAT INFORMATION.

NOBODY KNEW THAT INFORMATION. >> PRESIDENT TRUMP MET WITH TOP

>> PRESIDENT TRUMP MET WITH TOP PHARMACEUTICAL COMPANY

PHARMACEUTICAL COMPANY REPRESENTATIVES AT THE WHITE

REPRESENTATIVES AT THE WHITE HOUSE YESTERDAY WHERE THEY KEPT

HOUSE YESTERDAY WHERE THEY KEPT EXPLAINING TO HIM WHY IT’S GOING

EXPLAINING TO HIM WHY IT’S GOING TO TAKE SOME TIME TO DEVELOP A

TO TAKE SOME TIME TO DEVELOP A VACCINE FOR THE CORONAVIRUS.

VACCINE FOR THE CORONAVIRUS. >> WHEN DO YOU THINK YOU CAN

>> WHEN DO YOU THINK YOU CAN HAVE THE VACCINE, HAVE IT, START

HAVE THE VACCINE, HAVE IT, START PROVIDING

PROVIDING PRODUCING IT NOW.

PRODUCING IT NOW. >> WE’RE PRODUCING IT NOW.

>> WE’RE PRODUCING IT NOW. PROTEINS TAKE LONGER THAN SOME

PROTEINS TAKE LONGER THAN SOME OF THE OTHER WAYS, IT IS A

OF THE OTHER WAYS, IT IS A TECHNOLOGY THAT WORKS.

TECHNOLOGY THAT WORKS. WE COULD BE READY FOR CLINIC IN

WE COULD BE READY FOR CLINIC IN A YEAR, DEPENDING ON THE NATURE

A YEAR, DEPENDING ON THE NATURE OF HOW THE EPIDEMIC GOES OR

OF HOW THE EPIDEMIC GOES OR DOESN’T GO, YOU KNOW, WE WOULD,

DOESN’T GO, YOU KNOW, WE WOULD, AND WITH HELP OF THE AGENCIES OF

AND WITH HELP OF THE AGENCIES OF THIS COUNTRY, PERHAPS --

THIS COUNTRY, PERHAPS -- >> WE HAVE ANTIBODIES IN DISHES,

>> WE HAVE ANTIBODIES IN DISHES, WE ARE SCREENING THEM, SELECTING

WE ARE SCREENING THEM, SELECTING THEM.

THEM. ANTICIPATE IF ALL GOES WELL,

ANTICIPATE IF ALL GOES WELL, 200,000 DOSES PER MONTH CAN COME

200,000 DOSES PER MONTH CAN COME OUT OF THE FACTORY IN NEW YORK

OUT OF THE FACTORY IN NEW YORK STARTING IN AUGUST.

STARTING IN AUGUST. UNIQUE THING ABOUT OUR

UNIQUE THING ABOUT OUR TECHNOLOGY.

TECHNOLOGY. >> YOU WOULD BE ABLE TO USE THE

>> YOU WOULD BE ABLE TO USE THE VACCINE THAT EARLY?

VACCINE THAT EARLY? >> DEPENDS WHAT WE SEE, HOW WE

>> DEPENDS WHAT WE SEE, HOW WE WORK CLOSELY WITH THE FDA, WHICH

WORK CLOSELY WITH THE FDA, WHICH WE WILL DO.

WE WILL DO. THE FDA ALREADY REACHED OUT TO

THE FDA ALREADY REACHED OUT TO US.

US. WE HAVE TO WORK CLOSELY --

WE HAVE TO WORK CLOSELY -- >> THE PROCESS WOULD BE FASTER?

>> THE PROCESS WOULD BE FASTER? >> WE ARE WORKING ON THE

>> WE ARE WORKING ON THE MATERIAL, AS SOON AS WE GET

MATERIAL, AS SOON AS WE GET PHASE ONE BILLS OUT OF NIH, WE

PHASE ONE BILLS OUT OF NIH, WE START PHASE TWO RIGHT AWAY.

START PHASE TWO RIGHT AWAY. >> WHAT IS THE TIMING?

>> WHAT IS THE TIMING? >> GET THE PHASE ONE START VERY

>> GET THE PHASE ONE START VERY SOON NOW, JUST WAITING FOR GREEN

SOON NOW, JUST WAITING FOR GREEN LIGHT.

LIGHT. THE PRODUCT IS AT THE NIH.

THE PRODUCT IS AT THE NIH. THEN IT WOULD BE A FEW MONTHS TO

THEN IT WOULD BE A FEW MONTHS TO GET HUMAN DATA THAT WILL ALLOW

GET HUMAN DATA THAT WILL ALLOW US TO START PHASE TWO.

US TO START PHASE TWO. >> IN THE NEXT FEW MONTHS, YOU

>> IN THE NEXT FEW MONTHS, YOU THINK YOU CAN HAVE A VACCINE.

THINK YOU CAN HAVE A VACCINE. >> YOU WOULDN’T HAVE A VACCINE,

>> YOU WOULDN’T HAVE A VACCINE, A VACCINE TO GO TO TESTING.

A VACCINE TO GO TO TESTING. >> AND HOW LONG WOULD THAT TAKE?

>> AND HOW LONG WOULD THAT TAKE? >> A FEW MONTHS BEFORE WE GET TO

>> A FEW MONTHS BEFORE WE GET TO PHASE TWO.

PHASE TWO. >> TALKING WITHIN A YEAR.

>> TALKING WITHIN A YEAR. HE IS TALKING A FEW MONTHS.

HE IS TALKING A FEW MONTHS. >> WE WILL BE THERE IN JUNE.

>> WE WILL BE THERE IN JUNE. >> IN A COUPLE OF MONTHS.

>> IN A COUPLE OF MONTHS. I LIKE THE SOUND OF A COUPLE

I LIKE THE SOUND OF A COUPLE MONTHS.

MONTHS. WHEN YOU SAY JUNE, NOT A

WHEN YOU SAY JUNE, NOT A COMPLETED VACCINE.

COMPLETED VACCINE. >> A VACCINE READY FOR TESTING

>> A VACCINE READY FOR TESTING PHASE ONE.

PHASE ONE. >> READY TO USE WHEN?

>> READY TO USE WHEN? READY TO USE?

READY TO USE? NEXT SEASON?

NEXT SEASON? >> ASSUMING THE VACCINE IS

>> ASSUMING THE VACCINE IS TOLERATED, SAFE AND EFFICACIOUS,

TOLERATED, SAFE AND EFFICACIOUS, I THINK THE QUESTION IS HOW WE

I THINK THE QUESTION IS HOW WE GET THE FDA TO EXPEDITE AS FAST

GET THE FDA TO EXPEDITE AS FAST AS POSSIBLE TO A FAST TRACK

AS POSSIBLE TO A FAST TRACK PROGRAM TO GET THROUGH PHASE TWO

PROGRAM TO GET THROUGH PHASE TWO AND TESTING.

AND TESTING. >> QUICKLY.

>> QUICKLY. THE SAME VACCINE COULD NOT WORK.

THE SAME VACCINE COULD NOT WORK. YOU TAKE A VOLUME I DID FLUSOLID

YOU TAKE A VOLUME I DID FLUSOLID WOULDN’T HAVE IMPACT ON CORONA?

WOULDN’T HAVE IMPACT ON CORONA? >> PROBABLY NO.

>> PROBABLY NO. >> WOW.

>> WOW. JOINING US, INFECTIOUS DISEASE

JOINING US, INFECTIOUS DISEASE DOCTOR, SENIOR SCHOLAR AT THE

DOCTOR, SENIOR SCHOLAR AT THE JOHNS HOPKINS CENTER FOR HEALTH

JOHNS HOPKINS CENTER FOR HEALTH SECURITY, THANK YOU SO MUCH FOR

SECURITY, THANK YOU SO MUCH FOR COMING ON THE SHOW.

COMING ON THE SHOW. SEEMS THE PRESIDENT WAS HAVING A

SEEMS THE PRESIDENT WAS HAVING A HARD TIME UNDERSTANDING THE

HARD TIME UNDERSTANDING THE TIMING OF WHEN A VACCINE MIGHT

TIMING OF WHEN A VACCINE MIGHT BECOME AVAILABLE, WHETHER OR NOT

BECOME AVAILABLE, WHETHER OR NOT THE FLU VACCINE COULD BE USED

THE FLU VACCINE COULD BE USED FOR IT, WHICH IT CAN’T.

FOR IT, WHICH IT CAN’T. WHAT ARE WE LOOKING AT FOR

WHAT ARE WE LOOKING AT FOR REALISTIC TIME LINE FOR VACCINE

REALISTIC TIME LINE FOR VACCINE AND HOW DOES THAT EFFECT THOSE

AND HOW DOES THAT EFFECT THOSE TODAY?

TODAY? >> THE VACCINE, THE DEVELOPMENT

>> THE VACCINE, THE DEVELOPMENT TIME IS MEASURED IN YEARS.

TIME IS MEASURED IN YEARS. IT IS NOT SOMETHING WE’LL SEE

IT IS NOT SOMETHING WE’LL SEE FOR 12 TO 18 MONTHS.

FOR 12 TO 18 MONTHS. WE ARE GOING AT RECORD SPEED,

WE ARE GOING AT RECORD SPEED, GETTING TO CLINICAL TRIALS,

GETTING TO CLINICAL TRIALS, THAT’S NOT GOING TO IMPACT

THAT’S NOT GOING TO IMPACT PEOPLE SICK NOW.

PEOPLE SICK NOW. IT IS IMPORTANT WORK TO DO, BUT

IT IS IMPORTANT WORK TO DO, BUT IT IS NOT GOING TO BE SOME

IT IS NOT GOING TO BE SOME RESCUE DURING THE FIRST WAVE OF

RESCUE DURING THE FIRST WAVE OF OUTBREAK OF THE VIRUS.

OUTBREAK OF THE VIRUS. >> TALK ABOUT THE FIRST WAVE

>> TALK ABOUT THE FIRST WAVE WHICH THE VACCINE WILL HAVE NO

WHICH THE VACCINE WILL HAVE NO IMPACT ON, TALKING ABOUT A

IMPACT ON, TALKING ABOUT A VACCINE AVAILABLE IN 12 TO 18

VACCINE AVAILABLE IN 12 TO 18 MONTHS, NOT A FEW MONTHS, WHICH

MONTHS, NOT A FEW MONTHS, WHICH THE PRESIDENT KEPT THINKING

THE PRESIDENT KEPT THINKING THAT’S WHAT HE HEARD.

THAT’S WHAT HE HEARD. WHAT ARE WE EXPECTING IN TERMS

WHAT ARE WE EXPECTING IN TERMS OF NUMBERS RISING AS TESTING

OF NUMBERS RISING AS TESTING GETS OUT INTO LOCALITIES, AND

GETS OUT INTO LOCALITIES, AND I’LL DOUBLE UP AND SAY HOW LONG

I’LL DOUBLE UP AND SAY HOW LONG WILL IT TAKE TO GET TESTING

WILL IT TAKE TO GET TESTING ACROSS THE ENTIRE COUNTRY.

ACROSS THE ENTIRE COUNTRY. >> WE’RE GOING TO SEE CASE

>> WE’RE GOING TO SEE CASE COUNTS INCREASE SUBSTANTIALLY

COUNTS INCREASE SUBSTANTIALLY ALL OVER THE UNITED STATES AS

ALL OVER THE UNITED STATES AS MORE TEST KITS COME ONLINE, MORE

MORE TEST KITS COME ONLINE, MORE STATE DEPARTMENTS ARE ABLE TO

STATE DEPARTMENTS ARE ABLE TO TEST.

TEST. WE’LL SEE MORE MILD CASES

WE’LL SEE MORE MILD CASES DIAGNOSED, WHICH IS GOOD.

DIAGNOSED, WHICH IS GOOD. WE’LL UNDERSTAND WHERE THE

WE’LL UNDERSTAND WHERE THE SPREAD OF VIRUS IS, UNDERSTAND

SPREAD OF VIRUS IS, UNDERSTAND WHAT COMMUNITY SPREAD MEANS AND

WHAT COMMUNITY SPREAD MEANS AND GET COMMUNITIES READY WHEN THEY

GET COMMUNITIES READY WHEN THEY SEE CASES ARE POPPING UP ALL

SEE CASES ARE POPPING UP ALL OVER.

OVER. I THINK IT WILL TAKE SOME TIME

I THINK IT WILL TAKE SOME TIME FOR COMPLETE TESTING AT ALL

FOR COMPLETE TESTING AT ALL HOSPITALS, COMMERCIAL

HOSPITALS, COMMERCIAL LABORATORIES.

LABORATORIES. MONTHS TO GET WHERE WE NEED TO

MONTHS TO GET WHERE WE NEED TO WITH TESTING.

WITH TESTING. WE NEED TO TEST LIKE WE DO FOR

WE NEED TO TEST LIKE WE DO FOR INFLUENZA, NEED IT IN THE HANDS

INFLUENZA, NEED IT IN THE HANDS OF CLINICIANS, BE ABLE TO TELL

OF CLINICIANS, BE ABLE TO TELL PEOPLE WHEN THEY HAVE THIS.

PEOPLE WHEN THEY HAVE THIS. WE WILL FIND MORE MILD CASES

WE WILL FIND MORE MILD CASES THAT BRING DOWN THE RATIO.

THAT BRING DOWN THE RATIO. >> WILLIE GEIST, APPRECIATE YOU

>> WILLIE GEIST, APPRECIATE YOU BRINGING EXPERTISE TO THE

BRINGING EXPERTISE TO THE CONVERSATION.

CONVERSATION. I WANT TO PUT TO YOU A QUESTION

I WANT TO PUT TO YOU A QUESTION WE ASKED DR. CAMPBELL LAST HOUR,

WE ASKED DR. CAMPBELL LAST HOUR, HOW YOU’RE LOOKING AT THIS.

HOW YOU’RE LOOKING AT THIS. THERE’S SOME PANIC SETTING IN

THERE’S SOME PANIC SETTING IN AMONG SOME PEOPLE, RUNS ON WATER

AMONG SOME PEOPLE, RUNS ON WATER AND FOOD AT GROCERY STORES.

AND FOOD AT GROCERY STORES. YOUR CLEAR EYED VIEW HOW

YOUR CLEAR EYED VIEW HOW AMERICANS SHOULD LOOK AT

AMERICANS SHOULD LOOK AT CORONAVIRUS TODAY.